Gene Panel May Predict Who Needs Rectal Cancer Surgery

Surgeons at M.D. Anderson Cancer Center in Houston have identified 87 genes that someday may tell doctors whether or not rectal cancer patients need surgery after chemotherapy and radiation.  The panel of genes predicted patients whose cancer appeared to be…  Read More

Rectal Tumor Regression After Presurgical Chemoradiation Predicts Survival

The more tumors shrink during chemotherapy and radiation before rectal cancer surgery, the better the chance that patients will survive and be cancer-free five years later. Doctors in Ireland developed a simple, three point, tumor regression grade or TRG, to…  Read More

Response to Radiation Treatment Before Surgery Improves Rectal Cancer Survival

Patients whose tumors shrink in response to radiation therapy before surgery for rectal cancer have both improved overall survival and improved disease-free survival.  However, even patients who responded to presurgical radiation did not reach survival rates for stage I rectal…  Read More

How to Treat Rectal Cancer after Surgery? A Clinical Trial

Focus on Clinical Trials Can adding Avastin® (bevacizumab) to FOLFOX therapy after surgery and presurgical chemoradiotherapy reduce recurrence and improve survival for patients with rectal cancer? A clinical trial to answer this question is underway and is looking for participants. …  Read More